Plan, Don’t Predict: Cannabis Leaders On Preparing For 2027

Cannabis businesses are preparing for 2027 amid uncertainty surrounding federal marijuana rescheduling and new restrictions on hemp-derived products, according to MJBizDaily. Although qualifying medical marijuana products moved to Schedule 3 in April, adult-use cannabis remains classified as Schedule 1, leaving questions about taxation, banking and federal compliance unresolved. Meanwhile, federal changes scheduled for Dec. 11 would exclude hemp-derived products containing more than 0.4 milligrams of total THC per container from the legal definition of hemp, potentially affecting much of the hemp beverage market. Industry leaders emphasize that businesses should plan around existing regulations rather than assume anticipated federal changes will deliver immediate financial benefits.

For business law firms, accounting firms, compliance consultants, commercial insurance providers, security companies, packaging suppliers and business technology providers, the changing regulatory environment underscores the importance of helping businesses manage risk and prepare for shifting requirements. Sellers can encourage these advertisers to emphasize regulatory expertise, recordkeeping, financial planning and operational support for businesses navigating complex state and federal rules.